ETF Clinical Case: Combined Electrochemical Treatment (CET) Sensory Gains Quantified by ETF
Background on CET
Combined Electrochemical Treatment (CET) is a newer form of therapy emerging from leading pain management providers for the treatment of neuropathic pain. CET combines a local anesthetic block with an Electronic Signal Treatment (EST), a sophisticated electrical cell signaling modality delivered to the affected aspects of the body transcutaneously (1).
A diabetic male patient with a six year history of refractory pedal neuropathic pain underwent 28 EST treatments and 4 nerve blocks over a 10 week period. Painful sensory symptoms and numbness subsided by 90%. Pre-treatment ETF128 timed vibration tests (TVT) at the first metatarsal heads were 0 seconds bilaterally. Post-treatment TVT readings were 6.9s on the right and 10.6s on the left demonstrating a clear improvement in vibratory sensation. These findings correlate well with new research suggesting nerve regrowth after CET confirmed by Epidermal Nerve Fiber Density testing (2).
1. Odell RH Jr, Sorgnard RE.Anti-inflammatory effects of electronic signal treatment. Pain Physician. 2008 Nov-Dec;11(6):891-907.
2. Carney, PM, et al. Regenerating Nerves Destroyed by Neuropathy. 5th International Congress on Neuropathic Pain. May 17, 2015. Nice, France.
*ETF clinical cases are presented to demonstrate the diagnostic utility of the ETF128. Cases are derived from actual ETF customer practices. Customers are encouraged to submit their own cases for future posts.